Precision Genomics Collaboratory News

The Duke University School of Medicine Precision Genomics Collaboratory offered pilot grant funding for early career investigators interested in COVID-19 research that broadly involves genomics/’omics

Pooling expertise in the Undiagnosed Diseases Network solves rarest of rare mysteries

A team of Duke University researchers has developed a lab-grown living lung model that mimics the tiny air sacs of the lungs where coronavirus infection and serious lung damage take place.

Transcription factor proteins are the light switches of the human genome. By binding to DNA, they help turn genes “on” or “off” and start the important process of copying DNA into an RNA template that acts as a blueprint for a new protein.

Lefkowitz Distinguished Lecture explores how genes affect lipid levels.

Nationwide program aims to build innovative and sustainable solutions to expand test access and uptake in underserved and vulnerable communities

A team of Duke Health scientists have identified biomarkers that accurately identify numerous viral infections across the clinical stages of disease, advancing a potential new way to guide treatment, quarantine decisions, and other clinical and public health interventions in the setting of endemic and pandemic infectious diseases. 

For the first time at Duke, the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, is awarding a Center of Excellence in Genome Science (CEGS) grant, to a group of Duke researchers, providing $14 million of research support over five years.

For the first time at Duke, the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, is awarding a Center of Excellence in Genome Science (CEGS) grant, to a group of Duke researchers, providing $14 million of research support over five years.

Yarui Diao, Ph.D. received a U01 grant, totaling $3 million in research funding for 5 years, from 4D Nucleome Consortium